These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1774431)

  • 41. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H; Shmugliakov N
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
    Kasper S; Kick H; Voll G; Vieira A
    Eur Neuropsychopharmacol; 1991 May; 1(2):107-11. PubMed ID: 1821699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
    Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased plasma serotonin in melancholic patients: a study with clomipramine.
    Sarrias MJ; Artigas F; Martínez E; Gelpí E; Alvarez E; Udina C; Casas M
    Biol Psychiatry; 1987 Dec; 22(12):1429-38. PubMed ID: 3676370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Psychological test methods in pharmacopsychiatry].
    Kieback DG
    Pharmacopsychiatria; 1982 Sep; 15(5):175-80. PubMed ID: 6757984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
    Giedke H; Gaertner H; Breyer-Pfaff U; Rein W; Axmann D
    Eur Arch Psychiatry Neurol Sci; 1986; 235(6):329-38. PubMed ID: 3527706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Activity of platelet serotonin receptors of patients with endogenous depression before and after treatment with antidepressive agents].
    Katasonov AB; Beliaev BS; Brusov OS; Zlobina GP; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):75-8. PubMed ID: 2633575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M; Darimont P; Lecoq A; De Nayer A; Evrard JL; Krémer P; Devoitille JM; Dierick M; Mertens C; Mesotten F
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
    Coppen A; Rama Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 May; 63(2):125-9. PubMed ID: 112630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder.
    Stahl SM; Lemoine PM; Ciaranello RD; Berger PA
    Psychiatry Res; 1983 Nov; 10(3):157-64. PubMed ID: 6320244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Den Boer JA; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone.
    Botros WA; Ankier SI; Priest RG; McManus IC; Steinert J; Samir ZY
    Br J Psychiatry; 1989 Oct; 155():479-82. PubMed ID: 2692763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
    Katz RJ; Lott M; Landau P; Waldmeier P
    Biol Psychiatry; 1993 Feb; 33(4):261-6. PubMed ID: 8471679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.